Guardian Pharmacy Services (GRDN) Revenue & Revenue Breakdown
Guardian Pharmacy Services Revenue Highlights
Latest Revenue (Y)
$1.23B
Latest Revenue (Q)
$344.33M
Main Segment (Y)
Corporate Segment
Guardian Pharmacy Services Revenue by Period
Guardian Pharmacy Services Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $1.23B | 17.42% |
| 2023-12-31 | $1.05B | 15.10% |
| 2022-12-31 | $908.91M | 14.75% |
| 2021-12-31 | $792.07M | 7.62% |
| 2020-12-31 | $735.96M | 5.39% |
| 2019-12-31 | $698.29M | 16.31% |
| 2018-12-31 | $600.37M | - |
Guardian Pharmacy Services generated $1.23B in revenue during NA 2024, up 17.42% compared to the previous quarter, and up 175.92% compared to the same period a year ago.
Guardian Pharmacy Services Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $344.33M | 4.56% |
| 2025-03-31 | $329.31M | -2.74% |
| 2024-12-31 | $338.57M | 7.69% |
| 2024-09-30 | $314.39M | 4.78% |
| 2024-06-30 | $300.04M | 8.94% |
| 2024-03-31 | $275.41M | -2.01% |
| 2023-12-31 | $281.07M | 6.97% |
| 2023-09-30 | $262.74M | 3.67% |
| 2023-06-30 | $253.44M | 1.80% |
| 2023-03-31 | $248.95M | 11.10% |
| 2022-06-30 | $224.08M | 6.17% |
| 2022-03-31 | $211.05M | 0.55% |
| 2021-12-31 | $209.89M | 3.09% |
| 2021-09-30 | $203.59M | 12.29% |
| 2021-03-31 | $181.31M | -3.83% |
| 2020-12-31 | $188.54M | 3.78% |
| 2020-09-30 | $181.67M | -2.03% |
| 2020-03-31 | $185.43M | 1.44% |
| 2019-12-31 | $182.79M | 13.49% |
| 2018-12-31 | $161.06M | - |
Guardian Pharmacy Services generated $344.33M in revenue during Q2 2025, up 4.56% compared to the previous quarter, and up 125.03% compared to the same period a year ago.
Guardian Pharmacy Services Revenue Breakdown
Guardian Pharmacy Services Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 |
|---|---|
| Corporate Segment | $1.23B |
Latest
Guardian Pharmacy Services's latest annual revenue breakdown by segment (product or service), as of Dec 24: Corporate Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 |
|---|---|---|
| Corporate Segment | $344.33M | $329.31M |
Latest
Guardian Pharmacy Services's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Corporate Segment (100.00%).
Guardian Pharmacy Services Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TDOC | Teladoc Health | $2.57B | $631.90M |
| GRDN | Guardian Pharmacy Services | $1.23B | $344.33M |
| HRMY | Harmony Biosciences | $714.73M | $200.49M |
| AZTA | Azenta | $656.32M | $143.94M |
| TXG | 10x Genomics | $610.78M | $154.88M |
| NVCR | NovoCure | $605.22M | $154.99M |
| UFPT | UFP | $504.42M | $151.18M |
| SDGR | Schrödinger | $207.54M | $59.55M |
| JANX | Janux Therapeutics | $10.59M | - |
| STAA | STAAR Surgical | $313.90K | $42.59M |
| EWTX | Edgewise Therapeutics | - | - |